Boston College, United States
Disclosure information not submitted.
Light-Responsive Nanocomposite Scaffolds for Controlled Delivery of Prodigiosin for Triple-Negative Breast Cancer Therapy
Saturday, October 11, 20251:00 PM - 1:15 PM PDT
